Stocks were firm on Monday morning, looking to add to the recovery bounce from Friday. Investors have now been given an opportunity to look for stocks that have pulled back that perhaps they have previously missed. Each morning of the week, 24/7 Wall St. reviews dozens of analyst research reports to find new investment and trading ideas for our readers. Some of the analyst calls cover stocks to buy, while other research reports cover stocks to sell or stocks to avoid.
These are this Monday’s top analyst upgrades, downgrades and initiations from Wall Street analysts.
Achillion Pharmaceuticals Inc. (NASDAQ: ACHN) was raised to Overweight from Neutral at Piper Jaffray with a $10 price target (versus $7.36 close and versus $7.90 early indications), and it was raised to Outperform from Market Perform at Wells Fargo.
Central European Media Enterprises Ltd. (NASDAQ: CETV) was raised to Neutral from Sell at Goldman Sachs.
Chuy’s Holdings, Inc. (NASDAQ: CHUY) was raised to Outperform from Market Perform at Raymond James.
Freeport-McMoRan Copper & Gold Inc. (NYSE: FCX) was raised to Buy from Hold with a $42 price target (versus a $36.49 close) at Argus.
Gilead Sciences Inc. (NASDAQ: GILD) was reiterated as Buy and the price target to $110 from $90 at Argus. The call reflects strong Sovaldi sales for Hep-C and continued growth from both new and established products.